Stephen P Breukelman

Title: The Innovations of Stephen P Breukelman

Introduction

Stephen P Breukelman is a notable inventor based in Bristol, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with .beta.-adrenoceptor antagonist activity. With a total of 2 patents to his name, Breukelman's work has the potential to impact medical treatments significantly.

Latest Patents

Breukelman's latest patents include two key inventions. The first is related to 5-phenyl-3[2H]-pyridazinone derivatives, specifically focusing on (isopropyl and tertiary butyl-amino-2-hydroxypropoxy)phenyl-3[2H]-pyridazinones, which exhibit .beta.-adrenoceptor antagonist activity. The second patent also pertains to pharmaceutical compositions containing these derivatives, emphasizing their potential therapeutic applications.

Career Highlights

Breukelman is currently associated with Smith Kline & French Laboratories Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through the development of new compounds.

Collaborations

Throughout his career, Breukelman has collaborated with notable colleagues, including Anthony Maitland Roe and William J Coates. These partnerships have likely contributed to the success and impact of his inventions.

Conclusion

Stephen P Breukelman is a distinguished inventor whose work in pharmaceuticals has led to valuable innovations. His contributions, particularly in the area of .beta.-adrenoceptor antagonists, highlight the importance of research and development in improving healthcare solutions.